Novocure Ltd (NVCR)
US$ 18.14-2.32%
Price Chart
Key Statistics
Market Cap
$ 1.91B
P/E Ratio
0.00
Revenue (TTM)
$ 621.71M
Volume
1.05M
52W High
$ 34.13
52W Low
$ 14.17
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
18.0354
200-Day MA
20.3454
52 Week High
34.13
52 Week Low
14.17
About NVCR
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United.
Employees
1488
Headquarters
Baar, Switzerland
CEO
Mr. William F. Doyle
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg